New hope for PCOS: drug combo may improve IVF outcomes

NCT ID NCT07604779

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding myoinositol or pioglitazone to metformin improves pregnancy rates in women with PCOS undergoing ICSI (a type of IVF). 150 women will take one of three drug regimens for one month before the procedure. Researchers will track fertilization, pregnancy, and miscarriage rates to find the best approach.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Metformin, myoinositol, and pioglitazone

What this could lead to

If successful, this could identify a better pre-treatment regimen to improve fertilization and pregnancy rates in women with PCOS undergoing ICSI.

What could go wrong

This is a small, early-phase trial with no blinding, so results may not be definitive. Side effects from the drugs are possible, and the study may not lead to a standard treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POLYCYSTIC OVARIAN SYNDROME (PCOS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

polycystic ovary syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beni-Suef University Hospital

    Banī Suwayf, Beni Suweif Governorate, 62521, Egypt